CALGARY, Feb. 11, 2020 /CNW/ - CanadaBis Capital Inc.
(TSX-V:CANB) ("CanadaBis" or "the Company") a
holder of a federal licence to cultivate, process and sell cannabis
under the Cannabis Act, has announced its strategic direction and
facility expansion focus for its subsidiary 1998643 AB LTD.
("Stigma Grow")
Stigma's focus is clear; they are a company committed to helping
their evolving industry deliver on the promise of the
highest-quality legal cannabis products. Their facility in
Red Deer Alberta acts as the
Company's cornerstone; providing the craft-quality plants needed to
supply for all four pillars of their integrated business model.
"We are advantageously positioned to grow and manufacture
products that will be among the highest quality and potency in the
market," said President & CEO, Travis
McIntyre. "Stigma Grow intends to leverage the ability our
own, top-quality flower, state-of-the-art technology, and the
insight provided by our skilled and experienced staff, to target
consumers and partner LPs that are looking for high-quality,
"bud-run" extract product variations."
Stigma Extracts
The Company anticipates a shift in consumer behaviour from a
focus on dry flower to a focus on concentrates in 2020 and beyond.
To prepare for this demand, the Company has spent six months
perfecting their systems and constructing a CIDI Lab to house
hydrocarbon extraction processing — positioning them to bring
difficult-to-produce products to market on a mass scale.
In addition to representing products that are in high demand,
Stigma concentrate products will be some of the first available in
the Canadian legal market.
Stigma's concentrates promise an extremely clean, consistent and
pure form of cannabis product, and Stigma's third-party processing
abilities have already captured the interest of several LPs looking
for service providers capable of facilitating the expansion of
their own lines of products.
Travis explains, "With the current CIDI Lab constructed and our
expansion plans well underway, we are perfectly positioned to take
on a large volume of toll processing for other LPs. We see this as
an opportunity for those who have flower who would like to expand
their offerings to address evolved demands of a growing
market."
At present, Stigma has signed agreements with several reputable
LPs to conduct concentrate manufacturing on their behalf, and
currently hold POs for provincial channels scheduled for a
late-March delivery of high-quality, terpene-rich, shatter, badder,
live res badder and live res caviar.
The Company is currently in talks for more partnerships and
expect to make another announcement in the coming weeks.
Indoor Cultivation
Although the Company sees a shift in focus from flower to
concentrates, they have not lost sight of the need to provide
high-quality craft cannabis, and recognize the synergistic
connection.
As with any Premium Product the best inputs generate the best
outputs. The combination of the two sets the stage for our
long-term plans as a craft-cannabis cultivator recognized for
high-quality in everything we produce. This ongoing commitment to
both sides of the cannabis market will allow us to control the
quality of our products, and always ensure an optimized
offering.
Stigma Grow currently operates 22,000 sq/ft of production space
and is in the midst of their Phase 2 expansion which will increase
this area to 66,000 sq/ft by mid-2020. Proudly offering
craft-quality products with optimal cannabinoid profiles, Stigma
Grow is the first Health Canada-licensed producer operating in the
Red Deer area.
Cannabis Root-Infusion
Stigma Roots seeks to bring the healing potential of cannabis
roots to a market seeking alternative treatment options from a wide
range of ailments. Unlike the leaves and buds of the cannabis
plant, which are strictly regulated, the roots of the cannabis
plant do not fall under the same, strict regulations; providing a
valuable opportunity to extend Stigma's products and brand
messaging to the general public.
By using the roots of a cannabis plant as the primary ingredient
in their lotions and balms, Stigma Roots offers three advantages:
(1)products capable of providing the relief and benefits people
seek; (2) a profit stream generated from roots that would typically
be wasted; and, (3) a way to reach an entirely new audience with
our message — one that may not typically engage with a recreational
cannabis brand.
INDICAtive Collection
The Company owns and operates a standalone retail location in
Red Deer Alberta's Gasoline Alley
— INDICAtive Collection. In addition to providing polish and
professionalism, INDICAtive Collection acts as a touch point for a
company focused on providing that which is currently lacking.
Far more than a pillar acting in and of itself, INDICAtive
Collection provides our cultivation and processing R&D
departments with first-hand statistical evidence of what sells,
what's trending and what is not widely accepted by the public. Not
only does this first-hand research help guide our retail inventory,
it also guides our efforts at the LP level; ensuring we are
producing products that will be in high-demand.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION: This news release includes certain
"forward-looking statements" under applicable Canadian securities
legislation. Forward-looking statements include, but are not
limited to, statements with respect to our business and operations
including development and expansion plans, filing Health Canada
notices, entering into third party processing agreements, getting
products to market and the timing thereof. Forward-looking
statements are necessarily based upon a number of assumptions that,
while considered reasonable, are subject to known and unknown
risks, uncertainties, and other factors which may cause actual
results and future events to differ materially from those expressed
or implied by such forward-looking statements. Such factors
include, but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; requirement for further
capital, delay or failure to receive board, shareholder or
regulatory approvals; the results of operations and such other
matters as set out in the Filing Statement available on SEDAR at
www.sedar.com. There can be no assurance that such statements will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such
statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
information prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted
to identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended.
CanadaBis Capital does not intend, and does not assume any
obligation, to update this forward-looking information except as
otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE CanadaBis Capital Inc.